Altogether, the roles of this important transcription factor in DS-associated alterations are just starting to emerge, warranting future efforts to clearly elucidate the implications of RUNX1 and its alternative splicing regulation on the different pathophysiological features of Trisomy 21. This evidence concerns the gene RUNX1 and Dravet syndrome.